<VariationArchive VariationID="832947" VariationName="NC_000017.11:g.(?_68512379)_(68524087_?)del" VariationType="Deletion" Accession="VCV000832947" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="821152" VariationID="832947">
      <GeneList>
        <Gene Symbol="PRKAR1A" FullName="protein kinase cAMP-dependent type I regulatory subunit alpha" GeneID="5573" HGNC_ID="HGNC:9388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="68413623" stop="68551316" display_start="68413623" display_stop="68551316" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="66508109" stop="66528910" display_start="66508109" display_stop="66528910" Strand="+" />
          </Location>
          <OMIM>188830</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000017.11:g.(?_68512379)_(68524087_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" innerStart="66508520" innerStop="66520228" display_start="66508520" display_stop="66520228" variantLength="11709" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_66508520)_(66520228_?)del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_66508520)_(66520228_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.11:g.(?_68512379)_(68524087_?)del AND Carney complex, type 1" Accession="RCV001033415" Version="3">
        <ClassifiedConditionList TraitSetID="3443">
          <ClassifiedCondition DB="MedGen" ID="C2607929">Carney complex, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-11-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11115848</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19293268</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3443" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1315" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carney complex, type 1</ElementValue>
                <XRef ID="Carney+complex%2C+type+1/7902" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008057" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNEY MYXOMA-ENDOCRINE COMPLEX</ElementValue>
                <XRef Type="MIM" ID="160980" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CNC1</ElementValue>
                <XRef Type="MIM" ID="160980" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Carney complex (CNC) is characterized by skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas. Pale brown to black lentigines are the most common presenting feature of CNC and typically increase in number at puberty. Cardiac myxomas occur at a young age, may occur in any or all cardiac chambers, and can manifest as intracardiac obstruction of blood flow, embolic phenomenon, and/or heart failure. Other sites for myxomas include the skin, breast, oropharynx, and female genital tract. Primary pigmented nodular adrenocortical disease (PPNAD), which causes Cushing syndrome, is the most frequently observed endocrine tumor in CNC, occurring in approximately 25% of affected individuals. Large-cell calcifying Sertoli cell tumors (LCCSCTs) are observed in one third of affected males within the first decade and in most adult males. Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are nonfunctioning thyroid follicular adenomas. Clinically evident acromegaly from a growth hormone (GH)-producing adenoma is evident in approximately 10% of adults. Psammomatous melanotic schwannoma (PMS), a rare tumor of the nerve sheath, occurs in an estimated 10% of affected individuals. The median age of diagnosis is 20 years.</Attribute>
                <XRef ID="NBK1286" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15090" />
                <XRef ID="15090" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301463</ID>
                <ID Source="BookShelf">NBK1286</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="1359" DB="Orphanet" />
              <XRef ID="C2607929" DB="MedGen" />
              <XRef ID="MONDO:0008057" DB="MONDO" />
              <XRef Type="MIM" ID="160980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357978" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_002734.4_17_Deletion (exons 1-5)|MedGen:C2607929" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196722" DateUpdated="2024-06-09" DateCreated="2020-04-15" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11115848</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19293268</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PRKAR1A are known to be pathogenic (PMID: 11115848, 19293268). This variant has not been reported in the literature in individuals with PRKAR1A-related conditions. This variant is a gross deletion of the genomic region encompassing exons 1 to 5 of the PRKAR1A gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 5 of the PRKAR1A gene. This is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKAR1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.(?_66508520)_(66520228_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2607929" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357978" TraitType="Disease" MappingType="XRef" MappingValue="C2607929" MappingRef="MedGen">
        <MedGen CUI="C2607929" Name="Carney complex, type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

